Gannex doses first subject in Phase II primary biliary cholangitis trial
Gannex Pharma has dosed the first subject in Phase II trial of ASC42 for the treatment of primary biliary cholangitis (PBC) patients.
Source: clinicaltrialsarena.com
Page 4 - Time Data Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Time Data Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Time Data Services Today - Breaking & Trending Today
Alopecia areata in the spotlight in time for possible treatment paradigm shift
Clinical Trials Arena looks at a potential shake-up in alopecia areata's treatment paradigm and an emerging treatment mechanism.
Source: clinicaltrialsarena.com
CCTG receives Canadian Cancer Society grant to run trials
The Canadian Cancer Trials Group (CCTG) has obtained a grant of $30m from CCS to guarantee continued access to impactful clinical trials.
Source: clinicaltrialsarena.com
Eucure doses first patient with triple antibody combo in solid tumour trial
Eucure Biopharma has dosed the first subject in Phase I trial of its YH003 along with YH001 and pembrolizumab for solid tumour in Australia.
Source: clinicaltrialsarena.com
Renal Cell Carcinoma accounts for 2.5% share of global Oncology clinical trial activity in 2021
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...
Source: clinicaltrialsarena.com